roche pma interesting , page-21

I agree but I am trying not to be blindsided by my position in this stock.

I was working on the premise that we would get 1-4 small research signatures and 1 or 2 small to mid size IVD through to Q3 2012 for cash flow in 2013.

I never imagined that Roche could be a serious contender this early.

If Roche is involved then I believe they would have tried exclsivity - logical for a big player but I hope Geoff stuck to his guns.

I am impressed with the potential in this new discovery and I like the silence coming from the company around it.

If it does turn ou to be Roche then you can understand why Geoff has been so 'glass is half full' for so long. It was only time and takeovers that have dampend his spirits occasionally.